ATON PORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 3.15 $ -0.15 (-4.53 %)    

Monday, 17-Nov-2025 15:43:29 EST
QQQ $ 601.67 $ 0.00 (0 %)
DIA $ 463.97 $ 0.00 (0 %)
SPY $ 663.70 $ 0.00 (0 %)
TLT $ 89.29 $ 0.00 (0 %)
GLD $ 372.47 $ 0.00 (0 %)
$ 3.16
$ 3.24
$ 2.90 x 500
$ 3.14 x 100
-- - --
$ 2.95 - $ 15.82
113,832
na
7.2M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON), a leading digital asset company focused on growing the Telegram ecosystem, today announce...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON) – AlphaTON Capital, a leading investm...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON), a specialized digital asset treasury...

Core News & Articles

AlphaTON Capital (NASDAQ:ATON), a leading digital asset infrastructure company focused on Telegram and the TON blockchain ecosy...

Core News & Articles

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyn...

Core News & Articles

Telegram's more than 1 billion monthly active users represent the world's largest untapped market for AI agents that ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION